Is Halozyme Therapeutics, Inc. technically bullish or bearish?

As of 31 October 2025, the technical trend for Halozyme Therapeutics, Inc. has changed from bullish to mildly bullish. The weekly MACD indicates a mildly bearish stance, while the monthly MACD remains bullish. The daily moving averages are mildly bullish, and Bollinger Bands show bullish signals for both weekly and monthly time frames. However, the KST and Dow Theory indicate no clear trend on both weekly and monthly levels.
In terms of performance, the stock has outperformed the S&P 500 over the past week with a return of 3.34% compared to 0.71%, but it has underperformed over the past month with a return of -1.35% against the S&P 500's 1.92%. Year-to-date, the stock has a strong return of 42.33% versus the S&P 500's 16.30%. Overall, the current technical stance is mildly bullish, driven primarily by the daily moving averages and Bollinger Bands.